SCHEMBL8003074

SCHEMBL8003074

Cc1ncnn1-c1ccc(-c2nc(-c3ccccn3)n(C)c2Sc2ccc(Cl)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.61
GRM5 P41594 2/20 0.41
GAA P10253 3/20 0.36
PPP1CA P62136 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.34
ALDH1A1 P00352 2/20 0.34
ALOX12 P18054 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
BRD4 O60885 1/20 0.34
BRD2 P25440 1/20 0.34
BRD3 Q15059 1/20 0.34
CREBBP Q92793 1/20 0.34
DCTPP1 Q9H773 1/20 0.33
KDM4E B2RXH2 2/20 0.33
FLT3 P36888 1/20 0.33
PTGS2 P35354 1/20 0.32
PRCP P42785 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7993064 0.88 FAAH (0.76) FAAHGRM5GAAPPP1CASMN1; SMN2
SCHEMBL8002399 0.88 FAAH (0.62) FAAHGRM5GAAPPP1CASMN1; SMN2
SCHEMBL7994178 0.86 FAAH (0.66) FAAHGRM5GAAPPP1CASMN1; SMN2
SCHEMBL8008516 0.85 FAAH (0.71) FAAHGRM5GAAPPP1CASMN1; SMN2
SCHEMBL8001996 0.85 FAAH (0.64) FAAHGRM5GAAPPP1CASMN1; SMN2
SCHEMBL8005654 0.84 FAAH (0.61) FAAHGRM5GAAPPP1CASMN1; SMN2
SCHEMBL1303609 0.84 FAAH (0.62) FAAHGRM5GAAPPP1CASMN1; SMN2
SCHEMBL1303678 0.83 FAAH (0.69) FAAHGRM5GAAPPP1CASMN1; SMN2
SCHEMBL1303133 0.83 FAAH (0.69) FAAHGRM5GAAPPP1CASMN1; SMN2
SCHEMBL1303197 0.83 FAAH (0.69) FAAHGRM5GAAPPP1CASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885GRM5 786/4885GAA 1269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.